Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 95 citing Oskarsson: Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy..... (0.10 sec) 

Gabapentin for the symptomatic treatment of painful neuropathy in patients with …

- sunpharma.com.mx [PDF] 
M Backonja, A Beydoun, KR Edwards, SL Schwartz, V … - Jama, 1998 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 977 - Related articles - BL Direct - All 11 versions

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized …


JS Gimbel, P Richards, RK Portenoy - Neurology, 2003 - AAN Enterprises
Results: At an average (SD) dose of 37 (21) mg per day (range 10 to 99 mg/d), CR oxycodone
provided more analgesia than placebo (p= 0.002) in the intent-to-treat cohort. From days 28 to
42, overall average daily pain intensity (least squares mean ±SE), rated in subject diaries ...
Cited by 274 - Related articles - BL Direct - All 5 versions

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, …


RW Richter, R Portenoy, U Sharma, L Lamoreaux, H … - Journal of Pain, 2005 - Elsevier
This was a 6-week, randomized, double-blind, multicenter study evaluating the efficacy of pregabalin
in the treatment of painful diabetic neuropathy. Two hundred forty-six men and women with painful
diabetic neuropathy received pregabalin (150 or 600 mg/day by mouth) or placebo. The ...
Cited by 197 - Related articles - All 9 versions

Pharmacologic treatment of pain in polyneuropathy


SH Sindrup, TS Jensen - Neurology, 2000 - AAN Enterprises
Tricyclic antidepressants and anticonvulsants have become the mainstay in the treatment of
pain in polyneuropathy. Within the last decade, controlled trials have shown that numerous other
drugs relieve such pain. To estimate the efficacy of the different treatments, the authors ...
Cited by 195 - Related articles - BL Direct - All 8 versions

Diabetic neuropathy: an intensive review


JJ Duby, RK Campbell, SM Setter, JR White, KA … - American Journal of …, 2004 - ASHP
160 Am J Health-Syst Pharm—Vol 61 Jan 15, 2004 ... J EREMIAH J OHN D UBY , R. K EITH
C AMPBELL , S TEPHEN M. S ETTER , ... J OHN R AYMOND W HITE , AND K RISTIN A. R ASMUSSEN
... J EREMIAH J OHN D UBY , P HARM .D., is General Practice Resident, Uni- versity of ...
Cited by 150 - Related articles - BL Direct - All 9 versions

[PDF] Painful sensory neuropathy


JR Mendell, Z Sahenk - N Engl J Med, 2003 - palliative.uab.edu
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence
supporting various strategies is then presented, followed by a review of formal guidelines, when
they exist. The article ends with the authors' clinical recommendations.
Cited by 135 - Related articles - View as HTML - BL Direct - All 12 versions

The pathogenesis and management of painful diabetic neuropathy: a review


MC Spruce, J Potter, DV Coppini - Diabetic Medicine, 2003 - interscience.wiley.com
Painful diabetic neuropathy has always been a challenging complication of diabetes
mellitus. Emerging theories suggest that early dysaesthesia associated with painful neuropathy
may act as a marker for the development of the 'at risk' foot, allowing preventative clinical ...
Cited by 90 - Related articles - BL Direct - All 5 versions

Mexiletine: a review of its therapeutic use in painful diabetic neuropathy

- adisonline.com [PDF] 
B Jarvis, AJ Coukell - Drugs, 1998 - ingentaconnect.com
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 692 1. Diabetic Neuropathy
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 693 2. Pharmacodynamic Properties of Mexiletine
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 694 2.1 Studies in Animal Models . . . . . . . . . . . . . . . . . . . ...
Cited by 67 - Related articles - BL Direct - All 4 versions

A treatment algorithm for neuropathic pain


M Namaka, CR Gramlich, D Ruhlen, M Melanson, I … - Clinical therapeutics, 2004 - Elsevier
Background: Neuropathic pain is a chronic pain syndrome caused by drug-, disease-, or
injury-induced damage or destruction of sensory neurons within the dorsal root ganglia of the
peripheral nervous system. Characteristic clinical symptoms include the feeling of pins ...
Cited by 67 - Related articles - All 3 versions

Pharmacologic management part 2: lesser-studied neuropathic pain diseases


MM Backonja, J Serra - Pain medicine, 2004 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 60 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google